Cabaletta Bio, Inc. (CABA)
NASDAQ: CABA · Real-Time Price · USD
3.165
-0.015 (-0.47%)
Mar 6, 2026, 10:21 AM EST - Market open
Cabaletta Bio Market Cap
Cabaletta Bio has a market cap or net worth of $304.68 million as of March 6, 2026. Its market cap has increased by 189.93% in one year.
Market Cap
304.68M
Enterprise Value
171.97M
1-Year Change
189.93%
Ranking
Category
Stock Price
$3.17
Market Cap Chart
Since October 25, 2019, Cabaletta Bio's market cap has increased from $235.53M to $304.68M, an increase of 29.36%. That is a compound annual growth rate of 4.13%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Protara Therapeutics | 329.03M |
| Sutro Biopharma | 327.92M |
| Foghorn Therapeutics | 323.66M |
| Rezolute | 321.48M |
| Immuneering | 320.91M |
| Puma Biotechnology | 317.47M |
| Aldeyra Therapeutics | 312.35M |
| XOMA Royalty | 308.33M |